Canada puts J&J vaccine rollout plans on hold

Health Canada holding off on Johnson & Johnson COVID-19 vaccine distribution

Health Canada holding off on Johnson & Johnson COVID-19 vaccine distribution

Johnson & Johnson is a single-shot vaccine, meaning a person is fully vaccinated after just one dose.

There are now four vaccine types being used in France: Those of AstraZeneca, Johnson & Johnson, Pfizer-BioNTech and Moderna.

The vaccines made by Pfizer-BioNTech and Moderna represent the bulk of the jabs given in the Scandinavian country of almost 6 million people. Administering a second dose is crucial to effectiveness of the other vaccines, and is also a challenge for Dr. Henry who has made a decision to delay second doses as long as possible in order to give as many people as possible a first dose of vaccine.

So far, there have been 17 cases of VITT recorded in the United States after 8 million doses were administered, vice chair of NACI Shelley Deeks said.

For reasons linked to extremely rare blood clotting issues, the AstraZeneca and Johnson & Johnson vaccines are only being given to patients aged over 55.

Emergent announced earlier this month that 15 million doses of the latter had been ruined by cross-contamination - a development that prompted the White House to put Johnson & Johnson in charge of the facility.

Four new Covid-19 cases at the border, none in community
The latest outbreak has prompted New Zealand's Ministry of Health to pause the trans-Tasman travel bubble with Western Australia . To date 27 people have got in touch with Healthline to say they were in the locations of interest at the relevant time.

The European Union also approved the drug last month and has ordered 400 million doses.

But Danish health officials said the current favourable epidemiological situation in the Scandinavian country meant it could do without the J&J jab, and would rely only on the Pfizer/BioNTech and Moderna vaccines.

According to Health Canada, the U.S. Food and Drug Administration recently inspected the Emergent BioSolutions facility and "noted multiple areas of concern".

"The Danish Health Authority has concluded that the benefits of using the Covid-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse those who receive the vaccine", the authority said in a statement.

Those shots will only be released for distribution once Health Canada ensures they've met its "high standards for quality, safety and efficacy", the federal department said in a statement Friday evening. Of the 10 million doses on order, entitled to 1.3 million doses.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.